Search
for
Sort by
Research 211–240 of 1000+
- Rapid hair depigmentation in patient treated with pazopanib
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- An overview of management of drug-induced hair and nail disorders
- Hair graying and loss induced by imatinib mesylate
- Gefitinib-induced hair alterations: Figure 1
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Periocular Manifestations of Afatinib Therapy
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- The existence of a linear system consisting of sympathetic endings in rat skin
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Drug-induced scarring and permanent alopecia
- Ancient lineages of the keratin-associated protein (KRTAP) genes and their co-option in the evolution of the hair follicle
- Hair Growth After Gefitinib Treatment
- Chelators Depigment and Inorease Elasticity of Mink Skin
- BIOCHEMICAL AND HISTOCHEMICAL STUDIES ON WHITE, BROWN AND BLACK SKIN REGIONS OF THE GUINEA PIG
- Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Non-invasive monitoring of low molecular weight biomarkers relevant to skin inflammation and cancer
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Axitinib-induced repigmentation of grey hair in a patient with metastatic renal cell carcinoma